Deucravacitinib: Benefits, Uses, and Latest Updates in Treatment

Deucravacitinib is an innovative oral medication designed to treat moderate to severe plaque psoriasis by selectively targeting TYK2, a key enzyme involved in the inflammatory process. This targeted mechanism helps reduce symptoms with improved safety and efficacy profiles. Shanghai Lizhuo Pharmaceutical Technology Co., Ltd., a leading China manufacturer, supplier, and factory, is proud to offer high-quality Deucravacitinib. With advanced production facilities and rigorous quality control, Shanghai Lizhuo Pharmaceutical ensures reliable supply and consistent excellence. As a trusted China-based pharmaceutical manufacturer, they specialize in delivering cutting-edge therapies to meet global healthcare needs. Their commitment to innovation and excellence positions them as a prominent supplier in the pharmaceutical industry, providing Deucravacitinib to support better patient outcomes worldwide.

Related Products